AMAG Pharma (AMAG) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results
February 17, 2016 7:00 AM ESTFourth quarter 2015 non-GAAP revenue up 137% to $120.6 million1Fourth quarter 2015 non-GAAP adjusted EBITDA increased 322% to $61.3 million1
Conference call scheduled for 8:00 a.m. ET today
WALTHAM, Mass., Feb. 17, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today reported unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2015.
2015 was... More
